Mansky, L. M., & Bernard, L. C. (2000). 3′-Azido-3′-Deoxythymidine (AZT) and AZT-Resistant Reverse Transcriptase Can Increase the In Vivo Mutation Rate of Human Immunodeficiency Virus Type 1. American Society for Microbiology.
Chicago ZitierstilMansky, Louis M., und Lisa C. Bernard. 3′-Azido-3′-Deoxythymidine (AZT) and AZT-Resistant Reverse Transcriptase Can Increase the In Vivo Mutation Rate of Human Immunodeficiency Virus Type 1. American Society for Microbiology, 2000.
MLA ZitierstilMansky, Louis M., und Lisa C. Bernard. 3′-Azido-3′-Deoxythymidine (AZT) and AZT-Resistant Reverse Transcriptase Can Increase the In Vivo Mutation Rate of Human Immunodeficiency Virus Type 1. American Society for Microbiology, 2000.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.